Home > Qtrly Results > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]

SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹402 Cr ₹307 Cr ₹258 Cr ₹231 Cr ₹253 Cr ₹220 Cr ₹231 Cr ₹348 Cr
Expenses ₹328 Cr ₹189 Cr ₹154 Cr ₹151 Cr ₹180 Cr ₹154 Cr ₹132 Cr ₹180 Cr
Operating Income ₹74 Cr ₹118 Cr ₹104 Cr ₹80 Cr ₹73 Cr ₹66 Cr ₹99 Cr ₹168 Cr
Other Income ₹11 Cr ₹16 Cr ₹14 Cr ₹18 Cr ₹17 Cr ₹14 Cr ₹20 Cr ₹11 Cr
Interest ₹6 Cr ₹3 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹2 Cr
Depreciation ₹27 Cr ₹20 Cr ₹17 Cr ₹13 Cr ₹17 Cr ₹13 Cr ₹12 Cr ₹13 Cr
Profit Before Tax ₹52 Cr ₹110 Cr ₹100 Cr ₹83 Cr ₹71 Cr ₹65 Cr ₹105 Cr ₹164 Cr
Profit After Tax ₹39 Cr ₹83 Cr ₹82 Cr ₹61 Cr ₹53 Cr ₹47 Cr ₹80 Cr ₹121 Cr
EPS ₹1.65 ₹3.26 ₹3.23 ₹2.39 ₹2.10 ₹1.84 ₹3.12 ₹4.74
Industry Peers & Returns1W1M1Y
SUVEN PHARMACEUTICALS 0.3% 1.6% 22%
SUN PHARMACEUTICAL INDUSTRIES -0.4% -0.9% 4.8%
DIVIS LABORATORIES -0.7% 1.6% 50.2%
CIPLA -1.7% -1.1% -2.3%
TORRENT PHARMACEUTICALS -1.1% 1.6% 13.7%
DR REDDYS LABORATORIES -4.3% -8% -4.4%
MANKIND PHARMA 6.8% 8% 20.9%
ZYDUS LIFESCIENCES -1.9% 0.1% -16.5%
LUPIN -4.3% -6.4% 4.6%

SUVEN PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

30.89 %

Y-o-Y

58.95 %

Quarters Revenues % Change
Mar2025 ₹402 Cr
30.89
Dec2024 ₹307 Cr
19.18
Sep2024 ₹258 Cr
11.72
Jun2024 ₹231 Cr
-8.79
Mar2024 ₹253 Cr
15.06
Dec2023 ₹220 Cr
-4.86
Sep2023 ₹231 Cr
-33.52
Jun2023 ₹348 Cr -

SUVEN PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

-37.50 %

Y-o-Y

0.30 %

Quarters Operating Profit % Change
Mar2025 ₹74 Cr
-37.50
Dec2024 ₹118 Cr
13.16
Sep2024 ₹104 Cr
30.13
Jun2024 ₹80 Cr
8.99
Mar2024 ₹73 Cr
10.99
Dec2023 ₹66 Cr
-33.01
Sep2023 ₹99 Cr
-41.20
Jun2023 ₹168 Cr -
Operating Margins
Q-o-Q

-52.24 %

Y-o-Y

-36.90 %

Quarters Operating Margin% % Change
Mar2025 18.3%
-52.24
Dec2024 38.32%
-5.05
Sep2024 40.36%
16.48
Jun2024 34.65%
19.48
Mar2024 29%
-3.53
Dec2023 30.06%
-29.59
Sep2023 42.69%
-11.56
Jun2023 48.27% -

SUVEN PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-53.50 %

Y-o-Y

-27.43 %

Quarters Profit After Tax % Change
Mar2025 ₹39 Cr
-53.50
Dec2024 ₹83 Cr
1.60
Sep2024 ₹82 Cr
34.90
Jun2024 ₹61 Cr
13.87
Mar2024 ₹53 Cr
14.16
Dec2023 ₹47 Cr
-41.23
Sep2023 ₹80 Cr
-34.04
Jun2023 ₹121 Cr -
PAT Margins
Q-o-Q

-64.49 %

Y-o-Y

-54.36 %

Quarters PAT Margin(%) % Change
Mar2025 9.63 %
-64.49
Dec2024 27.12 %
-14.74
Sep2024 31.81 %
20.77
Jun2024 26.34 %
24.83
Mar2024 21.1 %
-0.80
Dec2023 21.27 %
-38.22
Sep2023 34.43 %
-0.78
Jun2023 34.7 % -

SUVEN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-49.39 %

Y-o-Y

-21.43 %

Quarters EPS % Change
Mar2025 ₹1.65
-49.39
Dec2024 ₹3.26
0.93
Sep2024 ₹3.23
35.15
Jun2024 ₹2.39
13.81
Mar2024 ₹2.1
14.13
Dec2023 ₹1.84
-41.03
Sep2023 ₹3.12
-34.18
Jun2023 ₹4.74 -

You may also like the below Video Courses